✦ LIBER ✦
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
✍ Scribed by Anna Candoni; Giovanni Martinelli; Eleonora Toffoletti; Alexia Chiarvesio; Mario Tiribelli; Michele Malagola; Pier Paolo Piccaluga; Angela Michelutti; Erica Simeone; Daniela Damiani; Domenico Russo; Renato Fanin
- Book ID
- 104040735
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 307 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.